![IJMS | Free Full-Text | Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System? | HTML IJMS | Free Full-Text | Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System? | HTML](https://www.mdpi.com/ijms/ijms-13-14579/article_deploy/html/images/ijms-13-14579f3.png)
IJMS | Free Full-Text | Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System? | HTML
![Copaxone (Glatiramer Acetate Injection) in MS | Uses, Side Effects, and More | Multiple Sclerosis News Today Copaxone (Glatiramer Acetate Injection) in MS | Uses, Side Effects, and More | Multiple Sclerosis News Today](https://multiplesclerosisnewstoday.com/wp-content/uploads/2022/03/Copaxone.png?p=100713)
Copaxone (Glatiramer Acetate Injection) in MS | Uses, Side Effects, and More | Multiple Sclerosis News Today
![Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study - The Lancet Neurology Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2000998245/2003707403/gr1.gif)
Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study - The Lancet Neurology
![Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β - Multiple Sclerosis and Related Disorders Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β - Multiple Sclerosis and Related Disorders](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/4b73cd53-b666-4d1e-8979-cc1435d5a5c1/gr1.jpg)
Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β - Multiple Sclerosis and Related Disorders
![Randomized study combining interferon and glatiramer acetate in multiple sclerosis. - Abstract - Europe PMC Randomized study combining interferon and glatiramer acetate in multiple sclerosis. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3631288/bin/nihms444361f1.jpg)
Randomized study combining interferon and glatiramer acetate in multiple sclerosis. - Abstract - Europe PMC
Induction of a higher-ordered architecture in glatiramer acetate improves its biological efficiency in an animal model of multiple sclerosis - Biomaterials Science (RSC Publishing)
PLOS ONE: Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk
![Demonstration of equivalence of a generic glatiramer acetate (Glatopa™) - Journal of the Neurological Sciences Demonstration of equivalence of a generic glatiramer acetate (Glatopa™) - Journal of the Neurological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/923d8364-773d-4db5-9a66-616fa9d472fd/gr1_lrg.jpg)